Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it

Page 5 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.

• A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesCompletedNCT04591626Phase 3Results posted
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesCompletedNCT04560998Phase 3Results posted
• Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2DCompletedNCT04538352Phase 4Results posted
• A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without MetforminCompletedNCT04537923Phase 3Results posted
• EMI-EHP Weight Management and Type 2 Diabetes Pragmatic TrialTerminatedNCT04531176Phase 4Results posted
• Exenatide Once-weekly as a Treatment for Multiple System AtrophyCompletedNCT04431713Phase 2Results posted
• A Study of LY3502970 in Participants With Type 2 DiabetesCompletedNCT04426474Phase 1Results posted
• A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using TirzepatideCompletedNCT04407234Phase 1Results posted
• GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic ResponseCompletedNCT04387201Phase 4Results posted
• Study of Tirzepatide in Healthy ParticipantsCompletedNCT04311424Phase 1Results posted
• A Study of Tirzepatide in Overweight and Very Overweight ParticipantsCompletedNCT04311411Phase 1Results posted
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT04255433Phase 3Results posted
• Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.CompletedNCT04251156Phase 3Results posted
• A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT04235959Phase 1Results posted
• Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)CompletedNCT04216589Phase 2Results posted
• Use of a GLP-1R Agonist to Treat Opioid Use DisorderCompletedNCT04199728Phase 1/2Results posted
• Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide scCompletedNCT04189848Phase 4Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or OverweightCompletedNCT04184622Phase 3Results posted
• A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female ParticipantsCompletedNCT04172987Phase 1Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)CompletedNCT04166773Phase 2Results posted
• A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.CompletedNCT04153929Phase 2Results posted
• A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCompletedNCT04143945Phase 2Results posted
• Impact of Semaglutide on CD34+ EPC and Fat Derived MSCCompletedNCT04126603Phase 4Results posted
• A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesCompletedNCT04109547Phase 3Results posted
• A Research Study on How Well Semaglutide Works in Adolescents With Overweight or ObesityCompletedNCT04102189Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)CompletedNCT04093752Phase 3Results posted
• A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using TirzepatideCompletedNCT04081337Phase 1Results posted
• Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or ObesityCompletedNCT04074161Phase 3Results posted
• A Study of Tirzepatide at Different Injection Sites in Participants With Different Body SizesCompletedNCT04050670Phase 1Results posted
• A Study of Tirzepatide in Participants With Type 2 Diabetes MellitusCompletedNCT04050553Phase 1Results posted
• A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without MetforminCompletedNCT04039503Phase 3Results posted
• Effects of Semaglutide in HIV-Associated LipohypertrophyActive, not recruitingNCT04019197Phase 2Results posted
• A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesCompletedNCT04017832Phase 3Results posted
• A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCompletedNCT04007107Phase 2Results posted
• A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 DiabetesCompletedNCT03989232Phase 3Results posted
• A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 DiabetesCompletedNCT03987919Phase 3Results posted
• A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver DamageCompletedNCT03987451Phase 2Results posted
• Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney TransplantationCompletedNCT03961256Phase 2Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneCompletedNCT03954834Phase 3Results posted
• A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03951753Phase 1Results posted
• A Study of Tirzepatide in Participants With Impaired Liver FunctionCompletedNCT03940742Phase 1Results posted
• A Study of LY3502970 in Healthy ParticipantsCompletedNCT03929744Phase 1Results posted
• Treating PCOS With Semaglutide vs Active Lifestyle InterventionCompletedNCT03919929Phase 2/3Results posted
• A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesCompletedNCT03914326Phase 3Results posted
• A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesCompletedNCT03882970Phase 3Results posted
• A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 DiabetesCompletedNCT03861052Phase 3Results posted
• A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCompletedNCT03861039Phase 3Results posted
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT03819153Phase 3Results posted
• STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or ObesityCompletedNCT03811574Phase 3Results posted
• Multiple Ascending Dose Study of AMG 598 in Adults With ObesityCompletedNCT03757130Phase 1Results posted
• Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery PatientsTerminatedNCT03743025Phase 4Results posted
• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskCompletedNCT03730662Phase 3Results posted
• Daily Liraglutide for Nicotine DependenceCompletedNCT03712098Phase 2Results posted
• Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03693430Phase 3Results posted
• A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 DiabetesCompletedNCT03689374Phase 3Results posted
• The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy DrinkersTerminatedNCT03645408Phase 1Results posted
• Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle ProgramCompletedNCT03611582Phase 3Results posted
• Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic TrialCompletedNCT03596450Phase 4Results posted
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityCompletedNCT03574597Phase 3Results posted
• Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or ObesityCompletedNCT03552757Phase 3Results posted
• Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03548987Phase 3Results posted
• STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03548935Phase 3Results posted
• Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in ObesityCompletedNCT03523273Phase 2Results posted
• Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.TerminatedNCT03500484Early Phase 1Results posted
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCompletedNCT03495102Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney FunctionCompletedNCT03482024Phase 1Results posted
• Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOSCompletedNCT03480022Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Healthy ParticipantsCompletedNCT03375463Phase 1Results posted
• A Study of Dulaglutide in Healthy ParticipantsCompletedNCT03363906Phase 1Results posted
• Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in GlucosuriaCompletedNCT03331289Phase 4Results posted
• A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 DiabetesCompletedNCT03322631Phase 1Results posted
• A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 DiabetesCompletedNCT03315780Phase 4Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCompletedNCT03311724Phase 2Results posted
• Binge Eating Liraglutide InterventionTerminatedNCT03279731Phase 3Results posted
• Liraglutide Effects on Epicardial Fat Inflammatory GenesCompletedNCT03260881Phase 4Results posted
• Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 DiabetesCompletedNCT03191396Phase 3Results posted
• A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)CompletedNCT03175120Phase 3Results posted
• A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)CompletedNCT03172494Phase 3Results posted
• Bexagliflozin Drug/Drug Interaction Study With Exenatide InjectionCompletedNCT03167411Phase 1Results posted
• Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)CompletedNCT03158805Phase 2Results posted
• Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 DiabetesCompletedNCT03136484Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes MellitusCompletedNCT03131687Phase 2Results posted
• Effect of GLP-1 Receptor Agonism After Sleeve GastrectomyCompletedNCT03115424Phase 3Results posted
• Cardiovascular Effects of GLP-1 Receptor ActivationCompletedNCT03101930Phase 4Results posted
• Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes MellitusCompletedNCT03086330Phase 3Results posted
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)CompletedNCT03061214Phase 3Results posted
• Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass SurgeryCompletedNCT03048578Phase 4Results posted
• Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese SubjectsCompletedNCT03041792Phase 1Results posted
• Impact of Liraglutide 3.0 on Body Fat DistributionCompletedNCT03038620Phase 4Results posted
• Saxenda in Obesity Services (STRIVE Study)CompletedNCT03036800Phase 4Results posted
• GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 DiabetesTerminatedNCT03029351Phase 4Results posted
• Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With InsulinCompletedNCT03021187Phase 3Results posted
• Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 DiabetesCompletedNCT03018028Phase 3Results posted
• Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 DiabetesCompletedNCT03015220Phase 3Results posted
• Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes MellitusCompletedNCT03010683Not applicableResults posted
• Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DMCompletedNCT02981069Phase 4Results posted
• Exenatide Once Weekly for Smoking CessationCompletedNCT02975297Phase 1/2Results posted
• A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyCompletedNCT02973100Phase 2Results posted
• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.CompletedNCT02970942Phase 2Results posted
• LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.CompletedNCT02964247Phase 3Results posted

← Glucagon-Like Peptide-1 Receptor Agonists overview